Cymbalta Study Shows Less Male Sexual Dysfunction Than Lexapro
This article was originally published in The Pink Sheet Daily
Executive Summary
Lilly post-market study finds 37% of men treated with duloxetine experienced sexual worsening, compared with 59% for Forest’s Lexapro.